alexa Contact Editorial in Chief: Drug Metabolism and Toxicology Journals
ISSN: 2157-7609

Journal of Drug Metabolism & Toxicology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..
Dale Johnson Editor-in-Chief
Dale Johnson
President and CEO
Emiliem, Inc. and Elara Bioscience Inc
Tel: 510-642-7870

Dr. Dale Johnson is an Adjunct Professor of Molecular Toxicology at UC Berkeley where he teaches Computational Toxicology, Principles of Drug Action, and lectures in Pharmacogenomics. He has had previous academic appointments at University of Michigan, Western Michigan University, and St. John’s University. He is also currently President & CEO of Emiliem, Inc. a start-up biotech company in California and Michigan. He has over 30 years experience in biopharmaceutical research and development activities where he has led and managed small units in start-up companies to multi-national groups in large corporations. He has participated in the research and development of over 100 investigational molecules of which 15 have become marketed medicinal products in the U.S., Europe, and Japan, and is co-inventor on 6 issued patents. He received BS, Pharm.D, and Ph.D (Toxicology). degrees from the University of Michigan where he was an AFPE Fellow. He is a Diplomate of the American Board of Toxicology (DABT). Dr. Johnson is the co-author of over 100 published papers, abstracts, and book chapters; was journal co-editor of The Chemistry of Metabolic and Toxicological Processes section of Current Opinion in Drug Discovery & Development; is the Special Issue Editor of Advances in Computational Toxicology, International Journal of Molecular Science; and is on the Editorial Advisory Board for the Wiley book series on Technologies for the Pharmaceutical Industry. He is a member of the Green Ribbon Science Panel for the state of California’s Department of Toxic Substances Control and is a member of scientific advisory boards for privately held companies. His current research activities are focused on creating and rolling out a comprehensive infrastructure designed to support all relevant and available chemical-toxicity resources, extend to various model systems and “omics” data sets, and be applicable to human health from chemical exposures and to early and late stage drug research and development. He is an active member of AAAS, American Chemical Society, and the Society of Toxicology.

Research Interest

He is currently applying this knowledge and expertise in academics, therapeutic R&D, as well as on environmental issues through the State of California Green Chemistry Initiatives. He is currently a member of the Green Ribbon Science Panel for California Department of Toxic Substances Control. He is a Diplomate of the American Board of Toxicology, co-inventor on several issued and pending patents, and co-editor of the journal The Chemistry of Metabolic and Toxicological Processes, Current Opinion in Drug Discovery & Development.

Sanjib Bhattachayya Editor-in-Chief
Sanjib Bhattachayya
Department of Biomotility and Traffic Jam
Tohoku University
Tel:  819094707969

Biography: Tohoku University (WPI-AIMR), Japan; January, 2015–Present. → working on Bio-motility and Traffic Jam Related to Alzheimer Disease University of Barcelona, Spain, Juan de la Cierva Fellow; July, 2014–December, 2014. → Worked on metabolomics and effect of dietary phytochemicals on diabetics Kyoto University (WPI-iCeMS), Japan, Research Associate; March, 2013–June, 2014. → Worked on Artificial Nano Transporter to Combat Metabolic Disorders and Polymer Drug Delivery Formulation Bhabha Atomic Research Centre (BARC), India, K S Krishnan Fellow (a President of India Fellowship), March, 2012-March 2013. → Worked in Immunomodulation of Dendritic Cell by Nano Biomaterials Mayo Clinic, Rochester, USA, Senior Research Fellow, July, 2009-February, 2012. → Worked in Nanomedicine, Drug Delivery and Cancer Biology, Sulfur Amino Acid Metabolism in Tumor Development.

Research Interest

Medicinal Chemistry, Enzymology, Nano Drug Delivery and Formulation Chemistry, Cancer Metabolism, Molecular Biology, Translational Research

Maria Durisova Editor-in-Chief
Maria Durisova
Institute of Experimental Pharmacology and Toxicology
Slovak Republic
Tel: 00421 2 5477 5928

I am a senior a researcher affiliated with the Institute of Experimental Pharmacology and Toxicology, the Department of Pharmacology of Inflammation, Slovak Academy of Sciences Bratislava, 841 04 Slovak Republic. However, during my work in pharmacokinetics for several years, I utilized my knowledge of mathematics, based on my education, what is necessary for the development of accurate mathematical models in pharmacokinetics.

Research Interest

Pharmacokinetics, Pharmacodynamics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version